CNL Healthcare Properties, Inc. financial data

Symbol
CHTH on OTC
Location
Orlando, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 86% % 3.4%
Return On Equity -2% % 41%
Return On Assets -0.81% % 41%
Operating Margin 8.8% % 20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 175,274,045 shares 0%
Common Stock, Shares, Outstanding 175,274,000 shares 0%
Entity Public Float $1,100,000,000 USD -8.3%
Common Stock, Value, Issued $1,739,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 173,942,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 173,942,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $385,495,000 USD 7.3%
Revenue from Contract with Customer, Excluding Assessed Tax $357,349,000 USD 7.7%
General and Administrative Expense $9,562,000 USD 8.9%
Costs and Expenses $351,655,000 USD 5.6%
Operating Income (Loss) $33,840,000 USD 29%
Nonoperating Income (Expense) $43,683,000 USD 1.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $9,843,000 USD 45%
Income Tax Expense (Benefit) $745,000 USD 24%
Net Income (Loss) Attributable to Parent $10,589,000 USD 43%
Earnings Per Share, Basic 0 USD/shares 58%
Earnings Per Share, Diluted 0 USD/shares 58%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $57,696,000 USD 14%
Assets $1,301,738,000 USD -2.5%
Liabilities $608,129,000 USD -1.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $248,000 USD 92%
Retained Earnings (Accumulated Deficit) $54,610,000 USD -16%
Stockholders' Equity Attributable to Parent $693,609,000 USD -3.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $693,609,000 USD -3.7%
Liabilities and Equity $1,301,738,000 USD -2.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,300,000 USD 100%
Net Cash Provided by (Used in) Financing Activities $4,339,000 USD 70%
Net Cash Provided by (Used in) Investing Activities $2,259,000 USD 15%
Common Stock, Shares Authorized 1,120,000,000 shares 0%
Common Stock, Shares, Issued 187,958,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,702,000 USD
Deferred Tax Assets, Valuation Allowance $21,860,000 USD 0.16%
Depreciation $51,700,000 USD 3.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,644,000 USD 65%
Lessee, Operating Lease, Liability, to be Paid $154,020,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $28,598,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $28,048,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $29,171,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $20,946,000 USD 0.24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $29,756,000 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%